| J9271 | Injection, pembrolizumab, 1 mg | 33,400 | $40 | $1.4M |
| J9299 | Injection, nivolumab, 1 mg | 8,920 | $20 | $214.1K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 680 | $90 | $62.7K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 440 | $100 | $44.1K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 390 | $60 | $24.4K |
| G0498 | Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community… | 120 | $180 | $21.2K |
| J0185 | Injection, aprepitant, 1 mg | 14,690 | $1 | $14.7K |
| J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 160 | $90 | $13.4K |
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 1,170 | $10 | $11.7K |
| 99205 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider… | 70 | $160 | $11.3K |